The Science Behind the Headlines
The free Biotech Primer WEEKLY explains the science behind today’s headlines. Delivered each Thursday directly to your inbox.
A Bone To Pick With Osteoporosis Last week, the FDA approved Evenity, Amgen’s (Thousand Oaks, CA) new osteoporosis drug. Heralded as effective at rebuilding bone, the drug promises to be an important weapon in the fight against osteoporosis. Osteoporosis is the loss...read more
Biotech for Non-Scientists
Down the Hatch! Then What? When popping a pill, how often do we think about what happens next—to the pill, or to our bodies? Maybe we assume the body welcomes any extra help to soothe our headache or control our blood pressure. This WEEKLY looks into the mystery of...read more
AND THE BEAT GOES ON Earlier this week, most areas of North America and Europe observed the annual ritual of “springing forward.” People started setting their clocks ahead one hour in the U.S. in 1918. The federal government aimed to save electricity and increase...read more
Medical Devices & Diagnostics
A New Type of Liquid Biopsy Biopsy. It can bring to mind painful cutting, punching and poking. Thankfully, these important and potentially life-saving procedures have moved into the new millennium along with the rest of us. Liquid biopsies have become a hot area of...read more